Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.655 USD | +3.22% | +2.17% | +10.33% |
07/05 | Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | Transcript : Inozyme Pharma, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.33% | 28Cr | |
+30.34% | 4.82TCr | |
-0.20% | 4.17TCr | |
+43.06% | 4.1TCr | |
-5.31% | 2.88TCr | |
+10.80% | 2.56TCr | |
-22.05% | 1.9TCr | |
+8.83% | 1.29TCr | |
+28.55% | 1.2TCr | |
-2.91% | 1.18TCr |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Wedbush Trims Inozyme Pharma's Price Target to $35 From $37; Outperform Rating Kept